Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients
Clinical trial NCT03904628 · UNKNOWN
Trial details
- NCT number
- NCT03904628
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2020-08-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.